Legal Representation
Attorney
Erica L Han
USPTO Deadlines
Application History
47 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Jun 6, 2022 | MAB6 | E | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED | Loading... |
| Jun 6, 2022 | ABN6 | S | ABANDONMENT - NO USE STATEMENT FILED | Loading... |
| Nov 5, 2021 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Nov 4, 2021 | EX5G | S | SOU EXTENSION 5 GRANTED | Loading... |
| Oct 29, 2021 | EXT5 | S | SOU EXTENSION 5 FILED | Loading... |
| Nov 4, 2021 | AITU | A | CASE ASSIGNED TO INTENT TO USE PARALEGAL | Loading... |
| Oct 29, 2021 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Apr 27, 2021 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Apr 23, 2021 | EX4G | S | SOU EXTENSION 4 GRANTED | Loading... |
| Apr 23, 2021 | EXT4 | S | SOU EXTENSION 4 FILED | Loading... |
| Apr 23, 2021 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Apr 15, 2021 | CHAN | I | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | Loading... |
| Apr 15, 2021 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | Loading... |
| Apr 15, 2021 | COAR | I | TEAS CHANGE OF OWNER ADDRESS RECEIVED | Loading... |
| Nov 3, 2020 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Oct 30, 2020 | EX3G | S | SOU EXTENSION 3 GRANTED | Loading... |
| Oct 30, 2020 | EXT3 | S | SOU EXTENSION 3 FILED | Loading... |
| Oct 30, 2020 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Jun 26, 2020 | CHAN | I | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | Loading... |
| Jun 26, 2020 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | Loading... |
| Jun 26, 2020 | COAR | I | TEAS CHANGE OF OWNER ADDRESS RECEIVED | Loading... |
| Apr 18, 2020 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Apr 16, 2020 | EX2G | S | SOU EXTENSION 2 GRANTED | Loading... |
| Apr 16, 2020 | EXT2 | S | SOU EXTENSION 2 FILED | Loading... |
| Apr 16, 2020 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Oct 17, 2019 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Oct 15, 2019 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
| Oct 15, 2019 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
| Oct 15, 2019 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Aug 14, 2019 | CHAN | I | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | Loading... |
| Aug 14, 2019 | COAR | I | TEAS CHANGE OF OWNER ADDRESS RECEIVED | Loading... |
| Aug 8, 2019 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | Loading... |
| Aug 8, 2019 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | Loading... |
| Apr 30, 2019 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Mar 5, 2019 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Mar 5, 2019 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Feb 13, 2019 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Jan 24, 2019 | ALIE | A | ASSIGNED TO LIE | Loading... |
| Jan 9, 2019 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Jan 9, 2019 | XAEC | I | EXAMINER'S AMENDMENT ENTERED | Loading... |
| Jan 9, 2019 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | Loading... |
| Jan 9, 2019 | GNEA | F | EXAMINERS AMENDMENT E-MAILED | Loading... |
| Jan 9, 2019 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN | Loading... |
| Jan 6, 2019 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Oct 31, 2018 | ASGN | I | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP | Loading... |
| Sep 29, 2018 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Sep 27, 2018 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
Pharmaceutical preparations for the diagnosis, prevention, and treatment of central and peripheral nervous system diseases and disorders; pharmaceutical preparations for the diagnosis, prevention, and treatment of neurological, neuropsychological, and neurodegenerative diseases and disorders; pharmaceutical preparations for the diagnosis, prevention, and treatment of medical conditions in the field of neuroscience
Classification
International Classes
005
Disclaimers
The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"THERAPEUTICS"